Last reviewed · How we verify

NCT05534607: NEAR

Natives Engaged in Alzheimers Research - 'Ike Kupuna

Recruiting now NA Last updated 1 August 2024
What this trial tests

NA trial testing Ola Mau i ka Hula in Mild Cognitive Impairment in 192 participants. Currently enrolling.

Timeline
15 September 2022
Primary endpoint
15 June 2025
30 April 2027

Quick facts

Lead sponsorUniversity of Hawaii
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment192
Start date15 September 2022
Primary completion15 June 2025
Estimated completion30 April 2027
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Hawaii

Who can join

Adults 50 to 75, any sex, with Mild Cognitive Impairment or Subjective Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function over 12 months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The adaptation and evaluation of a culturally grounded lifestyle intervention to mitigate the risk of Alzheimer's disease and related dementias in Native Hawaiians and Pacific Islanders: A study protocol.
    Kaholokula JK, Buchwald D, MacLehose R, Look M, et al · · 2025 · cited 1× · PMID 42147774 · DOI 10.1016/j.ssmmh.2025.100429

Verify or expand the search:

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

Other University of Hawaii trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05534607.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing